The city of Sugar Land, Texas, currently has 1 active clinical trials seeking participants for Lymphoma research studies.
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission
This randomized phase III trial studies rituximab after stem cell transplant and to see how well it works compared with rituximab alone in treating patients with in minimal residual disease-negative mantle cell lymphoma in first complete remission. Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell transplant helps kill any cancer cells that are in the body and helps make room in the patient's bone m... Read More
Between 18 years and 70 years
Trial Updated:
Locations: Houston Methodist Sugar Land Hospital, Sugar Land, Texas
Conditions: CD20 Positive, Mantle Cell Lymphoma